20261015_Cell Salvage Supplemental_RFI_Response Form_2.xlsx

XLSX spreadsheet 54 KB Posted

Attached to
Operational Medicine Test and Evaluation Cell Salvage Supplemental - (AFMEDCOM)
Solicitation number
FA800326SS004
Issued by

About this file

This is a Request for Information (RFI) Response Form for a cell salvage device evaluation being conducted by the Department of the Air Force Materiel Command (AFMEDCOM) under solicitation number FA800326SS004. The RFI seeks market research to identify solutions capable of performing cell salvage, blood conditioning, and autonomous return with flow rate control to bridge the time to surgery in austere environments. The government is interested in both existing cleared devices and prototypes from large businesses and all categories of small businesses.

The response form outlines ten essential characteristics that potential vendors must address, including: FDA approval status or clear pathway to approval; use of FDA-cleared consumable items; real-time monitoring of device fluid pressure; ability to recover from any orientation within three minutes; cleared control and monitoring systems; user-selectable collection and return rates up to 1500 mL/min; gas exchange capability with selectable sweep gas flow rates up to 10 L/min; integrated hypothermia prevention through heating capability; and specific thermal performance (heating 450 cc of fluid from 2°C to 37°C). Vendors must indicate whether their device meets each requirement and provide detailed comments. The NAICS code 339112 (Surgical and Medical Instrument Manufacturing) may be used for this requirement. This is a pre-solicitation market research effort, and responses do not constitute binding offers or contracts.

View the file

Other files

File Type Posted
Cell Salvage Supplemental RFI.docx DOCX document

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Sheet1

Cell Salvage Essential Characteristics
#Detailed Requirement DescriptionCommentsMeets (Y/N)Vendor Comments
1Planned FDA pathwayFDA approved or pending approval (with clear pathway and plan for final approval)
2Comprised of FDA cleared consumable items
3Realtime monitoring of device fluid pressureClinical monitor
4Ability to recover from any orientation with in 3 minRecover from upset or severe tilting during use
5Cleared control/ monitoring system
6Collection rate user selectable 0-1500mL/ mindevice capability rate of fluid collection
7Return rate user selectable 0-1500mL/ mindevice capability rate of fluid return
8Gas exchange 0-10L/ min sweepdevice capability selectable sweep gas flow rate
9Prevent hypothermia during treatmentIntegrated heater prevents hypothermia from hemorrhage during use
10Heat 450cc of fluid from 2oC to 37oC, <20 minStandard atmosphere and pressure environment
11Total system weight <40 pounds
12Total system volume <8000 cubic inches
13Storage requirementsNo cold chain, sterile packaging lasts at least 1 year
14Collection and return runtime of 2 hours @ 500ml/min (With Heating)Runtime is based on battery power
15Collection and return runtime of 4 hours @ 500ml/min (No Heating)Runtime is based on battery power
16Refit consumable items within 7 minutes single operatorPrepare blood contact items for next patient
17Complete priming sequence within 15 minutes for a single operatorSimplified fluid priming system (dry to infusion)
18Clear emboli <40 micronPrepare blood for return or storage
19Limits hemolysis to <1% PFhg during useMeasured per discreet blood volume
20Automated emboli detectionUser selectable alert to size of emboli detection
21Can be used to prepare blood for later useFill blood bag
22Single user operationOne person operation with limited training (medic)
23Ability to treat hemorrhage without using donor (exogenous) blood products
Cell Salvage Preferences (Not Required)
1Man-portableSingle person move, lift, carry
2RuggedizedMIL-STD-810G Standards to include acceleration, vibration, acoustic noise, shock, pyroshock, temperatue, and sand/dust.
3Realtime monitoring of patient invasive BPClinical monitor/vitals monitor (Real-time monitoring of invasive BP would require an arterial line but not necessary. If possible, that is a plus for those situations where higher level providers are available.)
4Realtime monitoring of oxygen saturationClinical monitor non invasive vitals monitor
5Realtime monitoring of % HematocritClinical monitor non invasive blood monitor
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50

&"Times New Roman,Regular"&18Response Form #2

&G &"Arial,Regular"&10Page &P of &N image1.jpeg

File details come from the government source that posted it. Updated .